Form D · Other Technology
Ark Biotech Inc.
Westwood, MA · CIK 0001901028
Offering snapshot reported May 24, 2024 · SEC filing
- Reported sold
- $8.18M Offering amount: $11M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 10, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2024 | Initial | $8,180,267 | No comparison | 8 | SEC filing |
| Oct 24, 2022 | Initial | $5,000,000 | No comparison | 5 | SEC filing |
| May 3, 2022 | Initial | $5,999,992 | No comparison | 12 | SEC filing |
| Dec 23, 2021 | Initial | $2,500,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-514233
Source: Form D, filed May 24, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Irving Fain | Director |
| Yosef Avraham Quint | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
410 University Avenue, Dpt 10027
Westwood, MA, 02090
Westwood, MA, 02090